We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Drug Products » Pharmaceutical Regulation Under Gottlieb-Trump - Webinar Recording/Transcript

Other Options

Audio Recording/Transcript - Nov. 16, 2017

$287.00

Audio Recording/Transcript - Nov. 16, 2017

$258.00

Audio Recording/Transcript - Nov. 16, 2017

$244.00

Audio Recording/Transcript - Nov. 16, 2017

$230.00

Audio Recording/Transcript - Nov. 16, 2017

$215.00

Pharmaceutical Regulation Under Gottlieb-Trump - Webinar Recording/Transcript

$287.00
Drug Products

Product Details

Pharmaceutical Regulation under Gottlieb-Trump

In Part III of FDAnews’s Expert Insight Series, our panel takes up drug regulation, policy and enforcement.

It will be 10 months into the Trump administration and the drug regulation picture will be coming clearer. New drug policies will have been established. New Trump-Gottlieb appointees will be assuming office. Many new products will have been approved. And it will be coming clear how fundamental standards for approval will differ from the past.

Perhaps most important, specific policies will be starting to emerge: Product approvals, opioids, drug pricing, and more.

Given the fluid nature of events though, panelists are certain to range beyond the topic of the day. Even if you haven’t participated previously, be certain to take in the final session where panelists look to the shape of things to come — 2018, 2019 and beyond. Multiple registration is a bargain, with special pricing to lower your costs. Other installments include:

  • What We’ve Learned Since Scott Gottlieb Was Confirmed
  • Device Regulation under Gottlieb & Trump
  • Global Regulation under Gottlieb-Trump and a Look Ahead

If you are in drugs or biologics, you know this is the must-attend session.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing